Prolonged storage of transfused red blood cells (RBCs) is associated with hemolysis in healthy adults and inflammation in animal models. We aimed to determine whether storage duration affects markers ...

PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive non-viral vectorized gene therapies with minimally-invasive delivery technology, has reported the ...

Received initial purchase orders for recombinant bovine transferrin from customers in the cultivated meat industryCommercial launch of AlbuFree™ ...

Iron is essential for cellular respiration, DNA synthesis and numerous enzymatic reactions. Its transport in vertebrates relies on the iron‐binding glycoprotein transferrin, which circulates in plasma ...

Q1 2026 Earnings Call May 13, 2026 5:00 PM EDTCompany ParticipantsPing Rawson - Chief Financial OfficerJoseph Hazelton ...

Bank of America Global Healthcare Conference 2026 May 14, 2026 11:55 AM EDTCompany ParticipantsDaniel O'Connell - ...

Cash runway is expected to extend into Q2 2027, with management aiming to keep 2026 operating expenses generally in line with ...

Research Describes the Potential of JCR’s Platform Technologies, Including JUST-AAV Gene Therapy, to Facilitate Delivery of Therapies to the Central Nervous System -HYOGO, Japan--(BUSINESS WIRE)--JCR ...

Received initial purchase orders for recombinant bovine transferrin from customers in the cultivated meat industryCommercial launch of AlbuFree DX recombinant human albumin by Proliant Health & Biolog ...

Ring Therapeutics®, a life sciences company pioneering a new class of targeted medicines, today announced new data on its Vector Conjugate platform and VectorBricks™ in vitro manufacturing technology.

NextGen Jane, Inc. today announced results from a study showing that neurofilament light chain (NfL), a widely used marker of ...

The right approaches are demonstrating that it is possible to breach the defensively designed blood-brain barrier despite its fortifications.